Sales & Marketing Sponsored Are Insights leaders seeing real commercial value from AI ad... Day One Strategy’s second annual AI in Pharma State of Play report addresses the challenges Pharma Insights teams are facing as AI adoption continues.
Digital Why AI sovereignty is becoming a requirement for businesses The companies that will lead in this next phase are those that treat AI as an integrated part of their operational architecture.
Digital 5 cybersecurity guidelines for remote monitoring in clinical... Remote monitoring has many advantages in clinical trials.
R&D Connected customer data: a golden opportunity for pharma mar... Data is transforming life sciences, but many organisations are not using its full potential.
Sales & Marketing 7 commercial, sales, and marketing predictions for 2023 In 2022, life sciences companies have been hard at work breaking down silos to better serve patients and healthcare professionals (HCPs).
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.